Tumor promotion as a target for estrogen/antiestrogen effects in rat hepatocarcinogenesis (Q28322565)

Europe PubMed Central

PubMed publication ID

1672562

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1672562

25 October 2022

1 reference

1

Y P Dragan

0 references

Henry C Pitot

3

object named as

H C Pitot

0 references

author name string

Y. D. Xu

2

1 reference

Europe PubMed Central

PubMed publication ID

1672562

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1672562

full work available at URL

25 October 2022

language of work or name

English

0 references

publication date

January 1991

0 references

https://api.elsevier.com/content/article/PII:009174359190003M?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

https://api.elsevier.com/content/article/PII:009174359190003M?httpAccept=text/plain

25 October 2022

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

25 October 2022

0 references

20

0 references

issue

1

0 references

page(s)

15-26

0 references

cites work

An approach to the development of a short-term whole-animal bioassay to distinguish initiating agents (incomplete carcinogens), promoting agents, complete carcinogens, and noncarcinogens in rat liver.

1

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Biochemical characterisation of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine

25 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci.

25 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Altered hepatic foci: their role in murine hepatocarcinogenesis

25 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Studies on the mechanisms involved in multistage carcinogenesis in mouse skin

25 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Kinetics of induction and growth of precancerous liver-cell foci, and liver tumour formation by diethylnitrosamine in the rat

25 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Persistence of resistant putative preneoplastic hepatocytes induced by N-nitrosodiethylamine or N-methyl-N-nitrosourea

25 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

The phenotypic stability of altered hepatic foci: effects of withdrawal and subsequent readministration of phenobarbital.

25 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Cell cycle-dependent initiation of adenosine triphosphatase-deficient populations in adult rat liver by a single dose of N-methyl-N-nitrosourea

25 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Single GST-P positive liver cells--putative initiated hepatocytes

25 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

The quantitative analysis and stability of histochemical markers of altered hepatic foci in rat liver following initiation by diethylnitrosamine administration and promotion with phenobarbital

25 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Early appearance of histochemically altered hepatocyte foci and liver tumors in female rats treated with carcinogens one day after birth

25 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Application of quantitative stereology to the evaluation of phenotypically heterogeneous enzyme-altered foci in the rat liver

25 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Quantitative stereological evaluation of four histochemical markers of altered foci in multistage hepatocarcinogenesis in the rat.

25 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

The pharmacology and clinical uses of tamoxifen

25 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

The effect of estradiol-17-phenylpropionate and estradiol benzoate on N-nitrosomorpholine-induced liver carcinogenesis in ovariectomized female rats

25 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats

25 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Regression of liver cell adenomas associated with oral contraceptives

25 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

25 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Induction and promotion of gamma-glutamyltranspeptidase-positive foci in the liver of female rats treated with ethinyl estradiol, clomiphene, tamoxifen and their associations

25 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Effects of ethinyl estradiol and tamoxifen on liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats.

25 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine

25 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

The phenotypic stability of altered hepatic foci: effect of the short-term withdrawal of phenobarbital and of the long-term feeding of purified diets after the withdrawal of phenobarbital.

25 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Regulation and expression of four cytochrome P-450 isoenzymes, NADPH-cytochrome P-450 reductase, the glutathione transferases B and C and microsomal epoxide hydrolase in preneoplastic and neoplastic lesions in rat liver.

25 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Effect of chronic phenobarbital administration on the gamma-glutamyl transpeptidase activity of hyperplastic liver lesions induced in rats by the Solt/Farber initiation: selection process of hepatocarcinogenesis

25 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Gamma-glutamyl transpeptidase--its role in hepatocarcinogenesis

25 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis.

25 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

gamma-Glutamyltranspeptidase-negative phenotypic property of preneoplastic and neoplastic liver lesions induced by ciprofibrate does not change following 2-acetylaminofluorene administration.

25 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

Critical parameters in the quantitation of the stages of initiation, promotion, and progression in one model of hepatocarcinogenesis in the rat.

25 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/0091-7435(91)90003-M

25 October 2022

Identifiers